Cardiawave

Cardiawave has developed a Non-Invasive Ultrasound Therapy (NIUT) medical device for the treatment of valvular heart disease, particularly Calcific Aortic Stenosis (CAS), the most common heart valve disease in adults and one of the leading causes of cardiovascular mortality worldwide. Headquartered near Paris, Cardiawave is a member of the national research alliance RHU Stop AS and has held EN ISO 13485:2016 certification since 2019.